Iannello S, Prestipino M, Belfiore F. Genetic defi- ciency of factor VII and hemorrhagic diathesis. A case report and literature review. Panminerva Med 1998;40(3):226-38.
Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Rare bleeding disorders. Haemophilia 2008;14 Suppl 3:202-10.
Croom KF, McCormack PL. Recombinant factor Vila (eptacog alfa): a review of its use in congenital he- mophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. BioDrugs 2008;22(2):121-36.
Lim S, Zuha R, Burt T, Chacko J, Scott R, Mainwaring CJ. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency. Blood Coagul Fibrinolysis 2006; 17(8):667-71.
Siddiqui MA, Scott LJ. Recombinant factor Vila (Epta- cog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders. Drugs 2005;65(8):1161-77.
Peyvandi F, Mannucci P.M, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII defi- ciency. Haemophilia 1997;3: 242-6.
White B, Martin M, Kelleher S, Browne P, McCann SR, Smith OP. Successful use of recombinant FVIIa (No- voseven) in the management of pulmonary haemor- rhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency. Br J Haematol 1999;106(1):254-5.
Biron C, Bengler C, Gris JC, Schved JF. Acquired iso- lated factor VII deficiency during sepsis. Haemostasis 1997;27(2):51-6.
Mullighan CG, Rischbieth A, Duncan EM, Lloyd JV. Ac- quired isolated factor VII deficiency associated with severe bleeding and successful treatment with recom- binant FVIIa (NovoSeven). Blood Coagul Fibrinolysis 2004;15(4):347-51.
Franchini M. Recombinant factor VIIa: a review on its clinical use. Int J Hematol 2006;83(2):126-38.
Acquired Factor VII deficiency associated with pneumonia
Year 2011,
Volume: 2 Issue: 4, 460 - 462, 01.12.2011
Iannello S, Prestipino M, Belfiore F. Genetic defi- ciency of factor VII and hemorrhagic diathesis. A case report and literature review. Panminerva Med 1998;40(3):226-38.
Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Rare bleeding disorders. Haemophilia 2008;14 Suppl 3:202-10.
Croom KF, McCormack PL. Recombinant factor Vila (eptacog alfa): a review of its use in congenital he- mophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. BioDrugs 2008;22(2):121-36.
Lim S, Zuha R, Burt T, Chacko J, Scott R, Mainwaring CJ. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency. Blood Coagul Fibrinolysis 2006; 17(8):667-71.
Siddiqui MA, Scott LJ. Recombinant factor Vila (Epta- cog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders. Drugs 2005;65(8):1161-77.
Peyvandi F, Mannucci P.M, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII defi- ciency. Haemophilia 1997;3: 242-6.
White B, Martin M, Kelleher S, Browne P, McCann SR, Smith OP. Successful use of recombinant FVIIa (No- voseven) in the management of pulmonary haemor- rhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency. Br J Haematol 1999;106(1):254-5.
Biron C, Bengler C, Gris JC, Schved JF. Acquired iso- lated factor VII deficiency during sepsis. Haemostasis 1997;27(2):51-6.
Mullighan CG, Rischbieth A, Duncan EM, Lloyd JV. Ac- quired isolated factor VII deficiency associated with severe bleeding and successful treatment with recom- binant FVIIa (NovoSeven). Blood Coagul Fibrinolysis 2004;15(4):347-51.
Franchini M. Recombinant factor VIIa: a review on its clinical use. Int J Hematol 2006;83(2):126-38.
Yokuş, O., Balçık, Ö. Ş., & Albayrak, M. (2011). Acquired Factor VII deficiency associated with pneumonia. Journal of Clinical and Experimental Investigations, 2(4), 460-462. https://doi.org/10.5799/ahinjs.01.2011.04.0097
AMA
Yokuş O, Balçık ÖŞ, Albayrak M. Acquired Factor VII deficiency associated with pneumonia. J Clin Exp Invest. December 2011;2(4):460-462. doi:10.5799/ahinjs.01.2011.04.0097
Chicago
Yokuş, Osman, Özlem Şahin Balçık, and Murat Albayrak. “Acquired Factor VII Deficiency Associated With Pneumonia”. Journal of Clinical and Experimental Investigations 2, no. 4 (December 2011): 460-62. https://doi.org/10.5799/ahinjs.01.2011.04.0097.
EndNote
Yokuş O, Balçık ÖŞ, Albayrak M (December 1, 2011) Acquired Factor VII deficiency associated with pneumonia. Journal of Clinical and Experimental Investigations 2 4 460–462.
IEEE
O. Yokuş, Ö. Ş. Balçık, and M. Albayrak, “Acquired Factor VII deficiency associated with pneumonia”, J Clin Exp Invest, vol. 2, no. 4, pp. 460–462, 2011, doi: 10.5799/ahinjs.01.2011.04.0097.
ISNAD
Yokuş, Osman et al. “Acquired Factor VII Deficiency Associated With Pneumonia”. Journal of Clinical and Experimental Investigations 2/4 (December 2011), 460-462. https://doi.org/10.5799/ahinjs.01.2011.04.0097.
JAMA
Yokuş O, Balçık ÖŞ, Albayrak M. Acquired Factor VII deficiency associated with pneumonia. J Clin Exp Invest. 2011;2:460–462.
MLA
Yokuş, Osman et al. “Acquired Factor VII Deficiency Associated With Pneumonia”. Journal of Clinical and Experimental Investigations, vol. 2, no. 4, 2011, pp. 460-2, doi:10.5799/ahinjs.01.2011.04.0097.
Vancouver
Yokuş O, Balçık ÖŞ, Albayrak M. Acquired Factor VII deficiency associated with pneumonia. J Clin Exp Invest. 2011;2(4):460-2.